Shobha Ravipaty, PhDAssociate Director at Stoke Therapeutics
Shobha Ravipaty is an Associate Director in the DMPK & Bioanalytical, Immunogenicity and Biomarkers group at Stoke Therapeutics where she supports late discovery, pre-clinical and clinical development programs.
Prior to joining Stoke in 2019, Shobha worked at BPGbio (formerly Berg) where she led a team of scientists responsible for developing, qualifying/validating and implementing LC-MS or immunoassay based bioanalytical methods for quantitation of small molecule/protein therapeutics and biomarkers in a regulated environment (CLIA) to support non-clinical, clinical and diagnostic programs. Shobha started her career in the industry as a Scientist at Celerion focusing on regulated (GLP) bioanalysis. Shobha earned her PhD degree in Analytical Chemistry from Michigan Technological University and received postdoctoral training in mass spectrometry-based proteomics at Indiana University.
Preclinical Data for STK-002, an Antisense Oligonucleotide Being Developed for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), 4:15pmView Session